Semaglutide 10 Vial

Description

HD Labs

Semaglutide 10

Semaglutide GLP-1

10mg/vial

Semaglutide is a synthetic peptide analogue extensively studied for its role in incretin-mediated metabolic pathways. It functions as a GLP-1 (glucagon-like peptide-1) receptor agonist, a class of compounds investigated for their effects on:

• Glucose-dependent insulin secretion

• Regulation of hepatic glucose production

• Delayed gastric emptying

• Appetite-related signalling pathways

This product is supplied as a 10 mg lyophilised peptide vial, intended for informed purchasers who have independently researched the compound and have consulted appropriate healthcare professionals.

---

Clinical Trial Evidence (Phase 3)

Semaglutide has been evaluated in multiple large-scale Phase 3 clinical trial programmes.

• In Phase 3 trials conducted under controlled conditions, semaglutide demonstrated clinically meaningful and sustained reductions in body weight, with participants in certain studies achieving average weight reductions of approximately 14–15% over 68 weeks, depending on study design and protocol.

• Phase 3 programmes also assessed long-term safety, tolerability, and metabolic outcomes, and these data formed the basis for regulatory review and approval in various jurisdictions.

Results observed in clinical trials reflect controlled research environments and do not guarantee similar outcomes in other settings.

---

How Semaglutide Compares

Semaglutide is often discussed alongside newer incretin-based peptides:

• Semaglutide acts as a single-pathway GLP-1 receptor agonist

• Tirzepatide targets both GLP-1 and GIP receptors (dual agonist)

• Retatrutide additionally engages the glucagon receptor (triple agonist)

Semaglutide represents an established GLP-1–based compound within this broader class.

---

Important Information

• This product is supplied in a lyophilised peptide format

• Consultation with a licensed healthcare provider is essential prior to any consideration of use

• Results observed in clinical trials may not reflect real-world outcomes

---

Is it legal to buy in South Africa?

It is not a SAHPRA-registered medicine. All three actives fall under South Africa’s medicines-scheduling framework, and Ignite Muscles supplies it for research and educational purposes only. Any personal use should be discussed with a registered SA practitioner.